Patrick van Rheenen

Pediatric Gastroenterologist, Head IBD Unit

University Medical Center Groningen

Netherlands

Research Interests

Explore related searches

Professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Collaborators (5)

Bjorn Winkens

University of Maastricht

NETHERLANDS

View details

Michiel van Wijk

Visiting Professor

Catholic University of Leuven

BELGIUM

View details

Saskia Vande Velde

Ghent University Hospital

BELGIUM

View details

Marten Poley

Erasmus University Rotterdam

NETHERLANDS

View details

Arta Aliu

University of Maastricht

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Patrick van Rheenen

Research Interests

Explore related searches

Contact this professor

Articles (10)

Explorative study on the value of hepcidin in predicting iron non-responsiveness in paediatric inflammatory bowel disease.

Evaluation of the Newborn Screening Pilot for Sickle Cell Disease in Suriname Using the Non-Adoption, Abandonment, Scale-Up, Spread, and Sustainability (NASSS) Framework

Obtaining first-line induction in autoimmune hepatitis: aren’t we underestimating prednisolone?

Infliximab in paediatric inflammatory bowel disease

Performance of Eight Infliximab Population Pharmacokinetic Models in a Cohort of Dutch Children with Inflammatory Bowel Disease

Effects of interrupting the enterohepatic circulation in amatoxin intoxications.

Early infliximab trough levels in paediatric IBD patients predict sustained remission

Randomised clinical trial: First-line infliximab biosimilar is cost-effective compared to conventional treatment in paediatric Crohn's disease

Fatigue and Physical Activity Patterns in Children With Inflammatory Bowel Disease

Ustekinumab trough levels in children with Crohn's disease refractory to anti-tumor necrosis factor agents

Collaborators (5)

Bjorn Winkens

Michiel van Wijk

Saskia Vande Velde

Marten Poley

Arta Aliu

Make your next move.